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ABSTRACT 
 
A therapy development with recombinant protein is a new and potential innovation to destroy 
cancer stem cells (CSCs). Various ways of killing CSCs include the provision of polyvalent anti-
protein antibodies that code pluripotency. Therefore, it takes a mixture of Oct-4, c-Myc, Sox2, and 
Klf4 protein antigens that can stimulate the formation of polyvalent antibodies. This study aimed to 
construct Sox2 recombinant by identifying the target genes by reverse transcriptase PCR and then 
arranging their designs to be inserted into the cloning vector  pET101/D-TOPO®. The target gene was 
developed by finding the complete sequences of Sox2 nucleotides on the NCBI GenBank. The growth 
on LB-ampicillin agar plates was amplified by PCR to obtain colonies with pET101/D-TOPO® 
vectors and inserts of the pluripotent gene of CSCs, then the PCR results were observed through 
electrophoresis. A total of fifteen colonies have DNA bands with a base pair of about 300 bp in length. 
The recombinant clones produced Sox2 genes with a base length of 330 bp. 
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INTRODUCTION 
A stem cell is a cell with unique self-reproduction and renewability. Another uniqueness is 
pluripotency, that is, the ability to differentiate into various types of cells based on its environment 
(Lynch et al., 2006).
 
Cancer stem cells (CSCs) possess pluripotent characteristics expressed by major 
markers such as Oct-4, Sox2, c-Myc, and Klf4. These properties are associated with normal stem cells 
in a way that CSCs can perform self-renewal and differentiation into multiple types of cell and have a 
high survival rate (Shi et al., 2012).
 
Septelia et al. (2011) have isolated and cultured breast CSCs from patients to compare their 
pluripotency levels and their association with the expression of Oct4 marker in each cell fraction. 
Also, due to the identification of several cell surface markers, namely CD44+, CD24-, ESA+, and 
CD133+, in different breast CSC subpopulations, these CSCs are classified a heterogeneous cell 
population (Aulia, 2012). 
Molecularly, the pluripotency of stem cells is characterized by the expression of transcription 
factors and proteins on their surface, called cell surface markers. Based on the research conducted by 
Takashi K. and Yamanaka S. (2006), Sox2 is a transcription factor that promotes stem cells 
differentiation besides Oct4, Klf4, and c-Myc.
 
Sox2 has a vital role in cells determination, differentiation, and proliferation. An increase in 
Sox2 gene expression correlates with more severe breast cancer. Overexpression of Sox2 in MCF-7, a 
breast cancer line, causes cell proliferation and tumorigenesis in the G1/S phase transition of the cell 
cycle (Al-Dhfyan, 2013).
 
Sox proteins play an essential part during organogenesis and in the embryonic development of 
some tissues. In oncogenesis, stemness and pathways within the embryo can be reactivated. Members 
of Sox family have been found to regulate various tumors (Dong et al., 2004). Sox2 has been detected 
as an immunogenic antigen in a significant percentage of lung cancer patients
 
(Gure et al., 2000) and 
meningioma patients (Comtesse et al., 2005). In the pancreas, Sox2 expression is involved in the 
invasion and metastasis of pancreatic intraepithelial neoplasia (Sanada et al., 2006). It has been 
recently reported as a marker in gastric cancer  (Li et al., 2006) and prostate cancer (Sattler et al., 
2000) and identified as a lineage-survival oncogene in squamous cell carcinoma of the cell (Hussenet 
et al., 2010). Another investigation has also found it in the early stage of a variety of postmenopausal 
breast carcinomas and metastatic lymph nodes (Lengerke et al., 2011).
 
The particular characteristics of Sox2 can be used to estimate the presence of CSCs in a group 
of cancer cells. In other words, Sox2 is a marker that pinpoints the location of CSCs. The coding of 
this pluripotency factor can be traced by generating commercially available antibodies. However, 
because these antibodies are manufactured to locate healthy stem cells, the production of antibodies 
for cancer diagnosis in Indonesia requires the cloning process of genes that code the pluripotency of 
cancer stem cells in Indonesian patients. 
  
MATERIALS AND METHOD  
Materials 
The main research materials were Sox2-encoding RNAs isolated from breast cancer stem cells, 
which were obtained from the Cell Culture Laboratory for Cancer Stem Cells in the Department of 
Biochemistry FKUI. The other materials were the reaction mix kit SuperScript III First-Strand 
Synthesis SuperMix (Invitrogen, USA), PureLink PCR Purification Kit (Invitrogen, USA), High-
Speed Plasmid Mini Kit protocol (GeneAid, Taiwan), DreamTaq PCR Master Mix (Thermo Scientific, 
USA), KAPA HiFi HotStart ReadyMix kit (GeneAid, Taiwan), Escherichia coli DH5α (BPPT, 
Indonesia), vector pET101/D-TOPO (Invitrogen, USA), agarose (GE Healthcare, Sweden), Tris base 
(USB, USA), ethidium bromide, LB Broth (Sigma, Germany), LB Agar (Sigma, Germany), Bacto 
Agar (Becton, Dickinson & Company, France), CaCl2, glycerol (Mallinckrodt, Mexico), nuclease-free 
aquadest, Aqua Bidest (Brataco, Indonesia), and Aqua Dest (Brataco, Indonesia). 
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Primer Design 
The primer was designed using Serial Cloner and PerlPrimer programs. The complete sequences 
of mRNA and amino acid of the pluripotency marker Sox2 were obtained from the NCBI GenBank. 
Then, the DNA binding site was obtained from the UniProt website. Open reading frames (ORFs) of 
mRNA and active domain position of the sequence were determined with Serial Cloner. Using 
PerlPrimer, the research was able to produce a variety of primer pairs, i.e., forward and reverse primer, 
and then select the compatible primer. Afterward, an alignment was conducted between selected 
primers and the mRNA sequences (Marshall, 2004). 
 
Reverse transcriptase-PCR  
RT-PCR was executed using the SuperScript® III One-Step RT-PCR System with Platinum® 
Taq DNA Polymerase. The RT-PCR component consisted of 25 μl of 2x reaction mix, 1 μl of RNA 
(concentration= 300 ng), 1 μl of forward primer (concentration= 10 μM), 1 μl of reverse primer 
(concentration= 10 μm), 2 μl of SuperScript III Reverse Transcriptase, and 50 μl of nuclease-free 
water. The RT-PCR conditions were as follows: cDNA synthesis was carried out at 55°C for 30 
minutes; pre-denaturation at 94°C for 2 minutes; 40 cycles, each consisting of denaturation at 94°C for 
15 minutes, annealing at 60°C (Sox2), and extension at 68°C for a minute; post extension at 68°C for 5 
minutes (Wacker and Godard, 2005).
 
 
Polymerase chain reaction   
The RT-PCR purification product was amplified using KAPA HiFi HotStart ReadyMix kit. 
Mixtures of 9 μL of ddH2O, 0.75 μL of forward primer, 0.75 μL of reverse primer, 2μL of DNA 
template, and 12.5 μL of KAPA HiFi ready mix were placed in a 0.5 mL microtube. The PCR 
conditions were as follows: pre-denaturation at 95ºC for 5 minutes; 35 cycles, each consisting of 
denaturation at 98°C for 30 seconds, annealing at 60°C (Sox2 and Klf4) for 15 seconds, extension at 
72°C for 1 minutes; post extension at 72°C for 5 minutes (Mathieu et al., 2014).
 
 
 
pET101/D-TOPO vector cloning 
The cloning reaction was completed by putting the following components into a microtube: 4μl 
of fresh PCR product; 1 μl of salt solution; 1μl of pET TOPO® vector. Then, the microtube was 
incubated on ice, and the mixed components transformed into DH5α competent E. coli (Mathieu et al., 
2014). 
 
Production of competent cells 
One colony of E. coli was taken from the stock, incubated for 16-20 hours at 37ºC, and 
transferred into a test tube containing 10 ml of LB broth, then incubated overnight at 37ºC with 
stirring. Subsequently, 0.4 ml of culture was injected into 10 ml of new and sterile LB liquid medium 
and incubated for 3 hours at 37ºC with stirring. Aseptically, 1.5 mL of culture was inserted into a 
sterile microtube and centrifuged at 5000 rpm for a minute in a refrigerated microcentrifuge. The cells 
pellet was washed with 1 mL of cold 0.1M CaCl2 and set aside on ice for 15 minutes. The 
centrifugation was conducted at 5000 rpm for one minute, and the cells pellet was suspended in 200 
μL of cold CaCl2 solution, then set aside on ice for 10 minutes. Afterward, the competent cells were 
ready to use (Mathieu et al., 2014). 
 
Transformation of  target gene 
One hundred μL of sterile 0.1M CaCl2 was inserted into a sterile microtube and added with a 
sample of the ligation product and 200 μL of DH5α competent  E. coli. For the control, the sample was 
replaced with ddH20. Then, it was incubated on ice for 90 minutes and stirred with the index finger 
every 10 minutes. A heat shock was delivered at 42ºC for 90 seconds without shaking. The tube was 
transferred to the ice for 2 minutes, added with 250μl of SOC medium at room temperature, tightly 
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sealed, and shaken horizontally at 200rpm, 37°C, for 90 minutes. The transformed suspension was 
spread on the LB agar medium containing ampicillin and incubated overnight at 37°C. The grown 
colonies were selected and replicated by streaking and picking the colonies then placing them into a 
new LB-ampicillin agar. These selected colonies were incubated overnight at 37ºC. The replica was 
used for further analysis through plasmid isolation (Mathieu et al., 2014).
  
 
Analysis of  transformation  
The plasmid was isolated using the High-Speed Plasmid Mini Kit Protocol. The Sox2-DNA 
association was amplified with the KAPA HiFi HotStart ReadyMix kit. Mixtures of 9 μL of ddH2O, 
0.75 μL of forward primer, 0.75 μL of reverse primer, and 2 μL of DNA template were put into a 0.5 
mL microtube. Then, 12.5 μL of KAPA HiFi ready mix was added into the mixture and centrifuged 
temporarily. The PCR conditions were as follows: pre-denaturation at 95°C for 5 minutes; 35 cycles, 
each consisting of denaturation at 98°C for 30 seconds, annealing at 60°C for 15 seconds, and 
extension at 72°C for one minute; post extension at 72°C for 5 minutes (Mathieu et al., 2014). 
 
Sequencing 
The sequence mapping was prepared to identify the sequence of the base pairs of Sox2. A 
verification was then performed to evaluate the absence or presence of a mutation. The sequencing 
reaction used the DNA Sequencing Service provided by the 1st BASE. The DNA sequencing results 
were analyzed in BioEdit 7.0.5.3 software (Tippmann, 2004). 
 
RESULT AND DISCUSSION  
Design of Sox2 primer 
The  Sox2 primer (NM_003106.3) was designed from the nucleotide base in the 558-737th 
order with the sequence of the forward primer for Sox2 as follows: 5'-
CACCATGAACATGATGGAGACGGAGCT-3'. Meanwhile, the sequence of the reverse primer was 
5'-GGGCCGGTATTTATAATCCGG-3'. The length of the Sox2 product generated from this primer 
pair was 330 bp. 
The sequence encoding the DNA-binding domain was input to the PerlPrimer program by 
adding triplicate bases at the beginning and the end of the strand of the sequence. The forward primer 
was added with seven bases of CACC ATG to adjust the cloning strategy. In this case, the addition of 
CACC was to allow the overhang of the Sox2 genes that would be inserted at the 5’ end of the cloning 
vector (GTGG), while ATG was added to initiate the formation of the start codon during the 
transcription process so that the protein could be expressed. The addition of CACC so that there is an 
overhang between the Sox2 gene which will be inserted into the 5 'end of the cloned vector (GTGG) 
while ATG is added so that the start codon is formed so the protein can be expressed. 
 
Reverse transcriptase-polymerase chain reaction 
The Sox2 RT-PCR products were collected with 2% gel electrophoresis, as visualized in   
Figure 1. The RT-PCR reaction was performed using the SuperScript® III One-Step RT-PCR System 
with Platinum
®
 Taq DNA Polymerase. The annealing temperature was adjusted to the melting 
temperature of the primer. The RT-PCR product of the Sox2 gene had a single band located by the 
benchmark length of the Sox2 product, i.e., 330 bp.  
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Figure 1. The RT-PCR analysis of Sox2 
 
Sequencing of PCR product  
The DNA of Sox2 was amplified using KAPA HiFi HotStart ReadyMix Kit. The PCR products 
were analyzed by sequencing to ensure that the formed bands were the genes of Sox2. Sequencing was 
conducted using the DNA Sequencing Service provided by 1st BASE using two reactions, i.e., forward 
and reverse. Based on the sequencing results of the Sox2 gene, the nucleotide bases were aligned using 
the Basic Local Alignment Search Tool (BLAST) on the NCBI website. 
The analysis results of the nucleotide-nucleotide BLAST (BLASTn) of the forward sequence of 
Sox2 showed 94% identity with the Sox2 sequence with the access code NM_003106.3, while the 
reverse one demonstrated 93% identity with the Sox2 sequence with the access code NM_003106.3. 
 
Transformation of Target Gene 
The target gene obtained in this research was the result of PCR with a blunt end. The growth of 
several colonies was detected in the agar medium but unidentified in the control medium. In the agar 
medium of Sox2, 15 colonies were found. 
 
 
Figure 2. pET100/D-TOPO
® 
vector 
 
The colonies that grew on the LB-ampicillin medium had been inserted with the pET101 vector 
(Figure 2). This vector has a site that is resistant to ampicillin; hence, the colony containing this vector 
was able to survive on the LB-ampicillin medium. However, these colonies require more analysis 
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concerning the successful transformations with PCR colonies. The results of the PCR plasmids of 
Sox2 suggested that all isolated plasmids comprised Sox2 (330 bp) genes (Figure 3). 
 
 
 
Figure 3. The PCR results of the colony from the insertion of the Sox2 gene (the annealing 
          temperature= 60°C) 
 
Sequencing of PCR colonies  
The PCR results of the colonies were analyzed using the same procedure as the sequencing of 
the PCR Product, that is sequencing and the use of 1
st
 BASE and BLAST software to define the 
nitrogenous bases of the Sox2 gene. The BLASTn analysis results depicted 92% identity with the Sox2 
sequence with the access code NM_003106.3 (Figure 4), meaning that the sequence of the colonies 
matches or shares 92% similarity with human Sox2 sequence in the NCBI data bank (Barton, 2007).  
 
 
 
Figure 4. The alignment analysis of the sequencing 
 
Pharmaciana ISSN: 2088 4559; e-ISSN: 2477 0256  
 
Construction of recombinant …(Rahmi et al., ) 
 
 
 
 
173 
CONCLUSION  
The designed forward and reverse primers have successfully amplified the active domain of 
Sox2, which controls the gene that codes pluripotency. The Sox2 genes have been successfully cloned 
to pET101/D-TOPO vectors and transformed into Escherichia coli DH5α host. The clone can be 
further developed to generate antibodies that can detect a cancer cell in Indonesian cancer patients. 
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